Form D · Biotechnology
biOasis Technologies Inc.
New Haven, CT · CIK 0001703978
Offering snapshot reported Jul 26, 2021 · SEC filing
- Reported sold
- $2.92M Offering amount: $4.53M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 26, 2021 | Initial | $2,918,525 | No comparison | Not reported | SEC filing |
| Dec 23, 2019 | Initial | $51,841 | No comparison | 1 | SEC filing |
| May 30, 2018 | Initial | $718,529 | No comparison | 6 | SEC filing |
| Apr 17, 2017 | Initial | $50,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-407668
Source: Form D, filed Jul 26, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christine Antalik | Executive |
| John E. Curran | Director |
| Judi Dalling | Executive |
| Mark Day | Director, Executive |
| Caroline Dircks | Executive |
| Ronald Peter Erickson | Director |
| Hans Christian Fibiger | Director |
| Gregory David Gubitz | Director |
| John Hemeon | Director |
| Robin Bruce Hutchison | Director, Executive |
| John Michael Hutchison | Director |
| Dave P. Jenkins | Executive |
| May Orfali | Executive |
| Terry William Pearson | Director |
| Maha Radhakrishnan | Director |
| Deborah Rathjen | Director, Executive |
| Mario Saltarelli | Director |
| Nancy Stagliano | Director |
| Mei Mei Tian | Executive |
| Dave Wurzer | Director |
| David M. Wurzer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
157 Church Street 19th Floor
New Haven, CT, 06510
New Haven, CT, 06510